Neoadjuvant SHR-1701 Plus Chemoradiotherapy for Locally Advanced Rectal Cancer
NCT07478731
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
48
Enrollment
OTHER
Sponsor class
Conditions
CRC (Colorectal Cancer)
Interventions
DRUG:
SHR-1701 neoadjuvant
Sponsor
Hong Qiu